TITLE

Pathology/cytology

PUB. DATE
August 1997
SOURCE
Clinical & Investigative Medicine;Aug97 Supplement, Vol. 20, pS69
SOURCE TYPE
Academic Journal
DOC. TYPE
Abstract
ABSTRACT
Presents an abstract of the research manuscript `Cutaneous B-cell infiltrates: Utility of morphologic, immunophenotypic and molecular data,' by A. Saxena and S. Angel.
ACCESSION #
9708236824

 

Related Articles

  • B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and classical Burkitt's lymphoma: A case report and review. Chettiankandy, Tabita Joy; Tupkari, Jagdish Vishnu; Kumar, Keshav; Ahire, Manisha Sandeep // Journal of Oral & Maxillofacial Pathology (0973029X);May-Aug2016, Vol. 20 Issue 2, p371 

    B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma (DLBCL) and classical Burkitt's lymphoma (BL), is a diagnostic provisional category in the World Health Organization 2008 classification of lymphomas. This category was designed as a measure to...

  • Nuclei micro-array FISH, a desirable alternative for MCL diagnosis. Chu, Hongjuan; Han, Xiqun; Jiang, Huiyong; Li, Feng; Li, Huiling; Zhao, Tong // Annals of Hematology;Nov2011, Vol. 90 Issue 11, p1299 

    Mantle cell lymphoma (MCL) is a rare, specific lymphoma subtype. Though the morphologic and immunophenotypic features of MCL have been well described in recent literatures, it is still a diagnostic dilemma because of its frequent confusion with other small B cell lymphomas (SBCLs). In the...

  • Symmetric palatal swelling as the first clinical manifestation of a mantle cell non-Hodgkin's lymphoma: A case report and review of literature. Scheller, Konstanze; Becker, Susann; Scheller, Christian // Journal of Oral & Maxillofacial Pathology (0973029X);Sep2011, Vol. 15 Issue 3, p311 

    The mantle cell lymphoma (MCL) is a rare (3.7%) low-grade non-Hodgkin lymphoma originating from the B-cell precursor-subpopulation. The clinical appearance in the oral cavity is rare. Since 1980, nine cases have been reported. A 41-year-old patient showed a MCL presenting with a symmetric,...

  • PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA DIAGNOSED AT DANBURY HOSPITAL AN EIGHT-YEAR RETROSPECTIVE REVIEW. Birusingh, Rhea J.; West, Jeffrey; Edwards, Leonel // Connecticut Medicine;Jan2009, Vol. 73 Issue 1, p23 

    Mediastinal Large B-cell lymphoma is a distinct entity in the World Health organization classification of mature B-cell lymphomas thought to originate from thymic B cells. It is relatively rare and mainly affects young woman and can have an aggressive clinical course. The neoplastic cells have a...

  • The Significance of Bone Marrow Involvement in Aggressive Lymphomas: A Retrospective Comparison of Clinical Outcomes between Peripheral T Cell Lymphoma and Diffuse Large B Cell Lymphoma in China. Shuhua Yi; Gang An; Junyuan Qi; Dehui Zou; Yaozhong Zhao; Peihong Zhang; Huishu Chen; Jun Wang; Lugui Qiu // Acta Haematologica;Dec2010, Vol. 124 Issue 4, p239 

    Background: Peripheral T cell lymphomas (PTCL) have been demonstrated to have a poorer prognosis than diffuse large B cell lymphoma (DLBCL) due to a high frequency of bone marrow involvement (BMI). However, the clinical characteristics of PTCL with BMI have not been fully described, and the...

  • Histiocytic/Dendritic Cell Transformation of B-Cell Neoplasms. Stoecker, Maggie M.; Wang, Endi // Archives of Pathology & Laboratory Medicine;Jun2013, Vol. 137 Issue 6, p865 

    B-cell lymphomas, such as low-grade follicular lymphoma and chronic lymphocytic leukemia/small lymphocytic lymphoma, can transform to histiocytic/dendritic cell sarcoma (H/DS) in rare cases. The diagnosis of this unconventional neoplastic evolution relies on a combination of...

  • Diagnosis of Splenic B-Cell Lymphomas in the Bone Marrow. Behdad, Amir; Bailey, Nathanael G. // Archives of Pathology & Laboratory Medicine;Oct2014, Vol. 138 Issue 10, p1295 

    Splenic B-cell lymphomas are a heterogeneous group of diseases comprising several entities that exhibit overlapping features. Diagnosis of these lymphomas has been reliant on the histopathologic examination of the spleen. However, with advances in diagnostic modalities and therapy, splenectomy...

  • Hodgkin Lymphoma and Anaplastic Variants of Non-Hodgkin Lymphoma. Tabrizchee, Hamid; Esmaili, Armita; Cogliatti, Sergio // Iranian Journal of Pathology;Fall2011, Vol. 6 Issue 4, p193 

    Background and Objectives: Classic Hodgkin lymphoma (CHL), anaplastic large cell lymphoma (ALCL) and some cases of diffuse large B cell lymphoma (DLBCL) have overlapping morphologic features. Since they all represent distinct clinico-pathologic entities, we explored the differential diagnostic...

  • Differentiating Between Burkitt Lymphoma and CD10+ Diffuse Large B-Cell Lymphoma. McGowan, Paul; Nelles, Nicole; Wimmer, Jana; Williams, Dawn; Wen, Jianguo; Li, Marilyn; Ewton, April; Curry, Choladda; Zu, Youli; Sheehan, Andrea; Chang, Chung-Che (Jeff) // American Journal of Clinical Pathology;Apr2012, Vol. 137 Issue 4, p665 

    The goal of this study was to evaluate routine flow cytometric (FC) immunophenotypic markers in differentiating between Burkitt lymphoma (BL) and CD10+ diffuse large B-cell lymphoma (DLBCL). We performed retrospective analysis of FC data from 55 patients. We evaluated 9 FC parameters: forward...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics